Pain and depression in myelin oligodendrocyte glycoprotein-antibody-related disease


  • Chronic pain and depression are common in myelin oligodendrocyte glycoprotein-antibody-associated disease and have a huge negative impact on quality of life and daily living.

Why this matters

    Little is known about the prevalence or impact of pain and depression in myelin oligodendrocyte glycoprotein-antibody-associated disease. These important findings reveal the high prevalence of both co-morbidities and their severe impact on quality of life and highlight the need for systematic pain assessment in this disease. In addition, pain was found to be undertreated, suggesting that targeted pain treatment strategies are urgently needed.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.